Search - tctmd.com

Displaying 241 - 260 of 534

Sort: Relevancy | Date

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Opinion CV Team Dispatch

September 2020 News Roundup

L.A. McKeown

September 01, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Michael O'Riordan

August 20, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Yael L. Maxwell

August 06, 2020

News Daily News

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

Todd Neale

July 28, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

Advertisement

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

September 2020 News Roundup

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Trimetazidine Safe but Not Protective Long-term After PCI

TCTMD’s Top 10 Most Popular Stories for August 2020

Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis

Could Statins Curb Fatal or Severe COVID-19? Some Clues

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

NSAIDs Boost CV, Bleeding Risks in Post-MI Patients

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Thrombus Burden Greater in STEMI Patients With COVID-19

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content